Depression of Insulin Release by Anti-GIP Serum after Oral Glucose in Rats
- 1 April 1981
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Gastroenterology
- Vol. 16 (3), 417-420
- https://doi.org/10.3109/00365528109181990
Abstract
An oral glucose tolerance test (OGTT), an OGTT after infusion of antigastric inhibitory polypeptide (GIP) serum and an i.v. glucose infusion were performed in unrestrained and unanesthetized rats. In the rats treated with anti-GIP serum the insulin release was significantly depressed. GIP is apparently a physiologically important glucose-dependent insulin-releasing peptide.This publication has 10 references indexed in Scilit:
- The Association between Plasma GIP and Insulin after Oral GlucoseScandinavian Journal of Gastroenterology, 1980
- Gastric Inhibitory Polypeptide (GIP) and Insulin Release after Small-Bowel Resection in ManScandinavian Journal of Gastroenterology, 1980
- Release of Gastric Inhibitory Polypeptide (GIP) by Intraduodenal Acidification in Rats and Humans and Abolishment of the Incretin Effect of Acid by GIP-Antiserum in RatsGastroenterology, 1979
- Gastrointestinal Hormones and the Control of Insulin SecretionDiabetes, 1978
- The response of Gastric Inhibitory Polypeptide (GIP) and insulin to glucose in duodenal ulcer patientsDiabetologia, 1978
- The Insulinotropic Action of Gastric Inhibitory Polypeptide in the Perfused Isolated Rat PancreasEndocrinology, 1976
- Gastric inhibitory polypeptide: Effect on glucose-induced insulin release from isolated rat pancreatic islets in vitroDiabetologia, 1975
- Ratio of Chymotrypsin to Trypsin in Human Duodenal AspirateDigestion, 1973